What is Teladoc Health's R&D?

Teladoc Health (TDOC) reported R&D of $67.87M in Q1 2026.

How has Teladoc Health's R&D changed year-over-year?

Teladoc Health's R&D decreased by 3.0% year-over-year, from $69.96M to $67.87M.

What is the long-term trend for Teladoc Health's R&D?

Over 4 years (2021 to 2025), Teladoc Health's R&D has grown at a -2.8% compound annual growth rate (CAGR), from $311.88M to $277.92M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Teladoc Health TDOC R&D

R&D at other companies

DoximityDOCS

$39.11M+57.7%

Omada Health, Inc. Common StockOMDA

$12.7M+44.2%

Hinge Health, Inc.HNGE

$30.34M+29.1%

Talkspace, Inc.TALK

$2.66M-6.2%

ICU MedicalICUI

$21.28M-8.6%

GE HealthCare TechnologiesGEHC

$345M+0.3%

Other financials

Income statement

See full

Revenue$613.8M-2.5%

Gross profit$416.3M-3.8%

Operating income-$61.8M+48.8%

Net income-$63.8M+31.4%

EPS (diluted)-$0.36+32.1%

Balance sheet

See full

Cash & equivalents$750.7M-37.1%

Total debt$42.2M-92.9%

Total equity$1.3B-6.4%

Total assets$2.8B-18.5%

Cash flow

See full

Operating cash flow$9.5M-40.2%

CapEx$1.7M-39.1%

Free cash flow$7.9M-40.5%

Valuation

See full

Market cap$1.41B+16.5%

Enterprise value$701.31M+14.7%

P/S0.6×+0.1×

Profitability

See full

Gross margin69.3%-1.2pp

Operating margin-8.1%-3.6pp

Net margin-6.8%-3.1pp

FCF margin11.1%-0.2pp

Returns & leverage

See full

Return on equity-12.4%-5.4pp

Debt / equity0×-0.4×

Current ratio2.8×+1.1×

Where this comes from

Reported directly by Teladoc Health in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teladoc Health's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Teladoc Health's R&D?: Teladoc Health (TDOC) reported R&D of $67.87M in Q1 2026.
How has Teladoc Health's R&D changed year-over-year?: Teladoc Health's R&D decreased by 3.0% year-over-year, from $69.96M to $67.87M.
What is the long-term trend for Teladoc Health's R&D?: Over 4 years (2021 to 2025), Teladoc Health's R&D has grown at a -2.8% compound annual growth rate (CAGR), from $311.88M to $277.92M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.